Literature DB >> 33679738

T Cell Receptor Beta-Chain Profiling of Tumor Tissue, Peripheral Blood and Regional Lymph Nodes From Patients With Papillary Thyroid Carcinoma.

Yizeng Wang1, Yuanchao Liu1, Li Chen1, Zuoyu Chen1, Xiaoning Wang1, Ruoyu Jiang1, Ke Zhao1, Xianghui He1.   

Abstract

Objective: To study the characteristics of the T cell receptor (TCR) repertoire in cancer tissue, peripheral blood and regional lymph nodes (LNs) from patients with papillary thyroid carcinoma (PTC).
Methods: PTC tissue, peripheral blood mononuclear cells (PBMCs) and regional LNs of six patients with papillary thyroid carcinoma were harvested. T cell receptor beta-chain (TCRβ) profiling was performed though high-throughput sequencing (HTS), and IMonitor, MiXCR and VDJtools were used to analyze the characteristics of the TCR repertoire.
Results: The results of IMonitor and those of MiXCR and VDJtools were very similar. The unique CDR3 of TCRβ from LNs was higher than that of PBMCs, and the CDR3 of TCRβ from LNs was higher than that of PTC tissue. Shannon's diversity index, D50, inverse Simpson index_mean and normalized Shannon's diversity index_mean of CDR3 from LNs were higher than those of PTCs and PBMCs. The HEC (high expansion clones) rate of CDR3 sequences at the amino acid level in PTC tissue was higher than that of PBMCs, which was higher than that of LNs. The V-J HEC rate of CDR3 was highest in PTC tissue, followed by PBMCs and LNs.
Conclusion: TCR CDR3 profiling showed differences among and within the PBMCs, PTC tissues and regional LNs of PTC, including unique CDR3, CDR3 HEC at the amino acid level, CDR3 V-J HEC at the amino acid level, Shannon's diversity index and D50. The TCRβ repertoire of PTC tissue, peripheral blood and regional LNs of PTC provide a reference for further study of immunity mechanisms against PTC.
Copyright © 2021 Wang, Liu, Chen, Chen, Wang, Jiang, Zhao and He.

Entities:  

Keywords:  T cell receptor; TCR repertoire; high expansion clones; high-throughput sequencing; papillary thyroid carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33679738      PMCID: PMC7930746          DOI: 10.3389/fimmu.2021.595355

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  32 in total

Review 1.  Immunosequencing: applications of immune repertoire deep sequencing.

Authors:  Harlan Robins
Journal:  Curr Opin Immunol       Date:  2013-10-16       Impact factor: 7.486

2.  TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.

Authors:  Ya-Bin Jin; Wei Luo; Guo-Yi Zhang; Kai-Rong Lin; Jin-Huan Cui; Xiang-Ping Chen; Ying-Ming Pan; Xiao-Fan Mao; Jun Tang; Yue-Jian Wang
Journal:  Cancer Immunol Immunother       Date:  2018-08-28       Impact factor: 6.968

3.  T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma.

Authors:  Zengchao Chen; Chaoting Zhang; Yaqi Pan; Ruiping Xu; Changqing Xu; Ziping Chen; Zheming Lu; Yang Ke
Journal:  J Pathol       Date:  2016-07-05       Impact factor: 7.996

4.  T-cell receptor diversity as a prognostic biomarker in melanoma patients.

Authors:  Julie Charles; Stephane Mouret; Isabelle Challende; Marie-Therese Leccia; Florence De Fraipont; Solene Perez; Nadia Plantier; Joel Plumas; Manuarii Manuel; Laurence Chaperot; Caroline Aspord
Journal:  Pigment Cell Melanoma Res       Date:  2020-02-03       Impact factor: 4.693

5.  Overview of methodologies for T-cell receptor repertoire analysis.

Authors:  Elisa Rosati; C Marie Dowds; Evaggelia Liaskou; Eva Kristine Klemsdal Henriksen; Tom H Karlsen; Andre Franke
Journal:  BMC Biotechnol       Date:  2017-07-10       Impact factor: 2.563

6.  T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.

Authors:  John F Beausang; Amanda J Wheeler; Natalie H Chan; Violet R Hanft; Frederick M Dirbas; Stefanie S Jeffrey; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-14       Impact factor: 11.205

7.  T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.

Authors:  Kai-Rong Lin; Fei-Wen Deng; Ya-Bin Jin; Xiang-Ping Chen; Ying-Ming Pan; Jin-Huan Cui; Zhi-Xuan You; Huan-Wei Chen; Wei Luo
Journal:  Cancer Med       Date:  2018-06-26       Impact factor: 4.452

8.  Determination of the complexity and diversity of the TCR β-chain CDR3 repertoire in bladder cancer using high-throughput sequencing.

Authors:  Jingsheng Ma; Guoping Sun; Peng Zhu; Song Liu; Minglin Ou; Zhiqiang Chen; Chang Zou; Frank Leing Chan; Yong Dai; Weiguo Sui
Journal:  Oncol Lett       Date:  2019-02-05       Impact factor: 2.967

9.  VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.

Authors:  Mikhail Shugay; Dmitriy V Bagaev; Maria A Turchaninova; Dmitriy A Bolotin; Olga V Britanova; Ekaterina V Putintseva; Mikhail V Pogorelyy; Vadim I Nazarov; Ivan V Zvyagin; Vitalina I Kirgizova; Kirill I Kirgizov; Elena V Skorobogatova; Dmitriy M Chudakov
Journal:  PLoS Comput Biol       Date:  2015-11-25       Impact factor: 4.475

10.  Association of the characteristics of B- and T-cell repertoires with papillary thyroid carcinoma.

Authors:  Guoping Sun; Lumei Qiu; Zhiqiang Cheng; Weibing Pan; Jingjun Qiu; Chang Zou; Ni Xie; Song Liu; Peng Zhu; Jun Zeng; Yong Dai
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

View more
  4 in total

1.  Distinct Injury Responsive Regulatory T Cells Identified by Multi-Dimensional Phenotyping.

Authors:  Fei Guo; Brandon Hancock; Alec Griffith; Hui Lin; Kaitlyn Howard; Joshua Keegan; Fan Zhang; Adam Chicoine; Laura Cahill; Julie Ng; James Lederer
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

2.  Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.

Authors:  Likun Cui; Chaoting Zhang; Huirong Ding; Dongdong Feng; Hongying Huang; Zheming Lu; Baoguo Liu
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

3.  High Expression of THBS1 Leads to a Poor Prognosis in Papillary Thyroid Cancer and Suppresses the Anti-Tumor Immune Microenvironment.

Authors:  Anqi Jin; Jin Zhou; Pengcheng Yu; Shichong Zhou; Cai Chang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 4.  T-Cell Receptor Repertoire Analysis with Computational Tools-An Immunologist's Perspective.

Authors:  Mahima Arunkumar; Christina E Zielinski
Journal:  Cells       Date:  2021-12-18       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.